About
Ni2o is a US-based company developing AI and brain-computer interface technologies aimed at early detection, continuous monitoring, and minimally invasive treatment of neurodegenerative diseases such as Alzheimer's, Parkinson's, and ALS.
Explore Ni2o's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.